Effects of bupropion on the forced swim test and release of dopamine in the nucleus accumbens in ACTH-treated rats

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 382, Issue 2, 2010, Pages 151-158

  Kitamura, Yoshihisa ^a   Yagi, Takahiko ^a   Kitagawa, Kouhei ^a   Shinomiya, Kazuaki ^a   Kawasaki, Hiromu ^a   Asanuma, Masato ^a   Gomita, Yutaka ^b  

^a OKAYAMA UNIVERSITY   (Japan)

^b SHUJITSU UNIVERSITY   (Japan)

Author keywords

Bupropion; Dopamine receptor; Dopamine release; Forced swim test; Nucleus accumbens; Treatment resistant depression

Indexed keywords

AMFEBUTAMONE; CORTICOTROPIN; DESIPRAMINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR; L 741626; NAFADOTRIDE; SODIUM CHLORIDE; TETRACOSACTIDE ZINC PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEPRESSION; DOPAMINE RELEASE; DRUG EFFECT; DRUG INFUSION; FORCED SWIMMING TEST; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMOBILIZATION; LOCOMOTION; MALE; MICRODIALYSIS; MICROINJECTION; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RAT;

ANIMALS; BUPROPION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COSYNTROPIN; DEPRESSION; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; IMMOBILIZATION; MALE; MICRODIALYSIS; MICROINJECTIONS; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE; SWIMMING;

EID: 77955552059     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-010-0521-x     Document Type: Article

References (28)

1. BJ Carroll GC Curtis J Mendels 1976 Neuroendocrine regulation in depression Arch Gen Psychiatry 33 1039 1044 1:STN:280:DyaE283ns12nug%3D%3D 962488
2. P Cassano L Lattanzi M Fava S Navari G Battistini M Abelli GB Cassano 2005 Ropinirole in treatment-resistant depression: a 16-week pilot study Can J Psychiatry 50 357 360 15999953
3. L Cervo R Samanin 1987 Evidence that dopamine mechanisms in the nucleus accumbens are selectively involved in the effect of desipramine in the forced swimming test Neuropharmacology 26 1469 1472 10.1016/0028-3908(87)90165-1 1:CAS:528:DyaL2sXmtFWrsrY%3D 3683762
4. L Cervo R Samanin 1988 Repeated treatment with imipramine and amitriptyline reduced the immobility of rats in the swimming test by enhancing dopamine mechanisms in the nucleus accumbens J Pharm Pharmacol 40 155 156 1:CAS:528:DyaL1cXhsVensLo%3D 2897457
5. BR Cooper TJ Hester RA Maxwell 1980 Behavioral and biochemical effects of antidepressant bupropion (Wellbutrin): evidence for selective blockade of desipramine uptake in vivo J Pharmacol Exp Ther 215 127 134 1:CAS:528: DyaL3cXlvFOktrk%3D 6778989
6. M Fava GI Papakostas T Petersen Y Mahal F Quitkin J Stewart P McGrath 2003 Switching to bupropion in fluoxetine-resistant major depressive disorder Ann Clin Psychiatry 15 17 22 12839429
7. T Inoue K Tsuchiya J Miura S Sakakibara K Denda T Kasahara T Koyama 1996 Bromocriptine treatment of tricyclic and heterocyclic antidepressant-resistant depression Biol Psychiatry 40 151 153 10.1016/0006-3223(95)00666-4 1:CAS:528:DyaK28XksFegs7c%3D 8793048
8. T Izumi T Inoue N Kitagawa N Nishi S Shimanaka Y Takahashi I Kusumi Y Odagaki K Denda T Ohmori T Koyama 2000 Open pergolide treatment of tricyclic and heterocyclic antidepressant-resistant depression J Affect Disord 61 127 132 10.1016/S0165-0327(99)00199-8 1:STN:280:DC%2BD3M7gt1ygtQ%3D%3D 11099751
9. S Jordan GL Kramer PK Zukas M Moeller F Petty 1994 In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine Synapse 18 294 297 10.1002/syn.890180404 1:CAS:528:DyaK2MXitlektbk%3D 7886621
10. K Kitagawa Y Kitamura T Miyazaki J Miyaoka H Kawasaki M Asanuma T Sendo Y Gomita 2009 Effects of pramipexole on the duration of immobility during the forced swim test in normal and ACTH-treated rats Naunyn Schmiedebergs Arch Pharmacol 380 59 66 10.1007/s00210-009-0405-0 1:CAS:528:DC%2BD1MXlvV2gs7w%3D 19274453
11. Y Kitamura H Araki Y Gomita 2002 Influence of ACTH on the effects of imipramine, desipramine and lithium on duration of immobility of rats in the forced swim test Pharmacol Biochem Behav 71 63 69 10.1016/S0091-3057(01)00625-6 1:CAS:528:DC%2BD38Xms1KjtQ%3D%3D 11812508
12. 2A receptor mRNA Biol Pharm Bull 31 246 249 10.1248/bpb.31.246 1:CAS:528:DC%2BD1cXmtlaks70%3D 18239281
13. SK Kulkarni MK Bhutani M Bishnoi 2008 Antidepressant activity of curcumin: involvement of serotonin and dopamine system Psychopharmacology 201 435 442 10.1007/s00213-008-1300-y 1:CAS:528:DC%2BD1cXhtlyjtLrE 18766332
14. B Levant R Nichole BA Vansell 1997 In vivo occupancy of D2 dopamine receptors by nafadotride Neuropsychopharmacol 17 67 71 10.1016/S0893-133X(97) 00024-9 1:CAS:528:DyaK2sXlt1Onu74%3D
15. B Li K Suemaru Y Kitamura R Cui Y Gomita H Araki 2007 Strategy to develop a new drug for treatment-resistant depression -Role of electroconvulsive stimuli and BDNF- YAKUGAKU ZASSI 127 735 742 10.1248/yakushi.127.735 1:CAS:528:DC%2BD2sXlslWrurY%3D
16. J Maj M Dziedzicka-Wasylewska R Rogoz Z Rogoz G Skuza 1996 Antidepressant drugs given repeatedly change the binding of the dopamine D2 receptor agonist [3H]N-0437, to dopamine D2 receptors in the rat brain Eur J Pharmacol 304 49 54 10.1016/0014-2999(96)00123-9 1:CAS:528:DyaK28Xjs1Wns7s%3D 8813583
17. BEP Murphy V Dhar AM Ghadirian G Chouinard R Keller 1991 Response to steroid suppression in major depression on resistant to antidepressant therapy J Clin Psychopharmacol 11 121 126 1:STN:280:DyaK3M3nslensw%3D%3D 1829098
18. DK Pandey R Rajkumar R Mahesh R Radha 2008 Depressant-like effects of parthenolide in a rodent behavioural antidepressant test battery J Pharm Pharmacol 60 1643 1650 10.1211/jpp/60.12.0010 1:CAS:528:DC%2BD1cXhsVyqu73M 19000369
19. MF Piacentini R Clinckers R Meeusen S Sarre G Ebinger Y Michotte 2003 Effects of bupropion on hippocampal neurotransmitters and on peripheral hormonal concentrations in the rat J Appl Physiol 95 652 656 1:CAS:528: DC%2BD3sXmsF2hu7Y%3D 12692144
20. R Rogoz MD Dzicka-Wasylewska 1999 Effect of antidepressant drugs on the dopamine D2/D3 receptors in the rat brain differentiated by agonist and antagonist binding - an autoradiographic analysis Naunyn-Schmiedeberg's Arch pharmacol 359 178 186 10.1007/PL00005340 1:CAS:528:DyaK1MXhtlKmtr4%3D
21. Z Rogoz G Skuza A Klodzinska 2004 Anxiolytic- and antidepressant-like effects of 7-OH-DPAT, preferential dopamine D3 receptor agonist in rats Pol J Pharmacol 56 519 526 1:CAS:528:DC%2BD2MXisVeitr4%3D 15591639
22. C Sanchez J Hyttel 1999 Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding Cell Mol Neurobiol 19 467 489 10.1023/A:1006986824213 1:CAS:528:DyaK1MXktFelsrg%3D 10379421
23. 1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants Brain Res 527 234 243 10.1016/0006-8993(90)91142-4 1:CAS:528:DyaK3cXmt1Cmsro%3D 1979237
24. SX Simon KW Perry DT Wong 2002 Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats Neuropharmacology 42 181 190 10.1016/S0028-3908(01)00160-5
25. N Sonino M Boscaro G Ambroso G Merola F Mantero 1986 Prolonged treatment of Cushing's disease with metyrapone and aminoglutethimide IRCS J Med Sci 14 485 486
26. G Tanda E Carboni R Frau G Di Chiara 1994 Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential? Psychopharmacology 93 193 200
27. P Willner 1997 The mesolimbic dopamine system as a target for rapid antidepressant action Int Clin Psychopharmacol 12 Suppl 3 S7 S14 10.1097/00004850-199707003-00002 9347387
28. J Yamada Y Sugimoto S Yamada 2004 Involvement of dopamine receptors in the anti-immobility effects of dopamine re-uptake inhibitors in the forced swimming test Eur J Pharmacol 504 207 211 10.1016/j.ejphar.2004.09.057 1:CAS:528:DC%2BD2cXpslGlsbk%3D 15541423